Companies building the tools, languages, and infrastructure for programming living cells — from genetic parts registries to automated biofoundry platforms.
Base editing, prime editing, and Cas-family tools used in research, agriculture, therapeutics, and industrial biotechnology applications.
Redesigning cellular metabolism to produce pharmaceuticals, fuels, materials, and food ingredients at industrial scale from renewable feedstocks.
Machine learning for protein design, gene circuit optimization, and automated experiment planning driving the next generation of biological R&D.
Engineered cells, synthetic gene circuits, and designer biologics delivering programmable medicines for cancer, autoimmunity, and rare disease.
Microbes and enzymes engineered to decarbonize manufacturing — from bio-based plastics to carbon capture and sustainable agriculture.
Synthetic biology is to the 21st century what information technology was to the 20th. The era has a name. Now it needs an address.
The domain that names this era should belong to one of them.
Begin Acquisition